1.
J Law Med Ethics
; 26(1): 38-47, 3, 1998.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11067584
RESUMEN
Authors argue that characterization of gene transfer research as "gene therapy" has compromised informed consent in the current environment of regulatory exceptions, routinized consent, fostered therapeutic misconceptions, and oversold research.